Article
Paclitaxel And Docetaxel Resistance: Molecular Mechanisms and Development of New Generation Taxanes
27 May 2007
Abstract excerpt
Taxanes represent one of the most promising classes of anticancer agents. Unfortunately, their clinical success has been limited by the insurgence of cellular resistance, mainly mediated by the expression of the MDR phenotype or by microtubule alterations. However, the remarkable relevance of paclitaxel and docetaxel in clinical oncology stimulated intensive efforts in the last decade to identify new derivatives...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
